Navigation Links
ULURU Inc. Announces Agreement With Exciton to Develop Antimicrobial Dressing
Date:1/19/2011

echt, President of Exciton Technologies Inc., stated, "We are delighted to be working with ULURU to develop a product containing two patented technologies which appear to work synergistically to potentially provide significant clinical advantages. The initial in-vitro testing clearly indicates that Altrazeal® exSALT™ has superior properties to the market leading products in this market category."

It is anticipated that a 510(k) application will be filed with the FDA in approximately 90 days. Assuming no extended delays in FDA review, approval of Altrazeal® exSALT™ could occur as early as the third quarter of 2011. The antimicrobial segment of the North American advanced wound care market is projected to grow in the next 5 years to be in excess of $750 million with annual growth rates above 15%.

Commenting on the Agreement, Kerry P. Gray, President and CEO of ULURU Inc., stated, "Combining these two leading technologies offers the potential for a dominant product in the antimicrobial dressing market. The superior antimicrobial activity at a significantly lower silver concentration is an outstanding product benefit. As we assessed our silver product strategy, given the favorable product profile of Altrazeal® exSALT™, it became obvious that this was our best course of action compared with pursuing our prior silver product application. This revised strategy also addresses questions previously raised by the FDA."

About ULURU Inc.:ULURU Inc. is a specialty pharmaceutical company focused on the development of a portfolio of wound management and oral care products to provide patients and consumers improved clinical outcomes through controlled delivery utilizing its innovative Nanoflex™ Aggregate technology and OraDisc™ transmucosal delivery system. For further information about ULURU Inc., please visit our website at www.uluruinc.com. For further information
'/>"/>

SOURCE ULURU Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. ULURU Inc. to Raise $500,000 in Registered Direct Offering
2. ULURU Inc. Reports Third Quarter 2010 Financial Results
3. ULURU Inc. Provides Altrazeal® Clinical Update
4. ULURU Inc. Announces Conference Call
5. ULURU Inc. Reports Second Quarter 2010 Financial Results
6. ULURU Inc. Invited to Present Altrazeal(TM) Research at 10th Annual Wound Healing Science and Industry Conference
7. ULURU Inc. Obtains Status of Approved Supplier With McKesson.
8. ULURU Inc. Announces Conference Call to Discuss Financial Results for the Third Quarter Ended September 30, 2009 and to Provide a Business Update
9. ULURU Inc. to Present Altrazeal(TM) Clinical Evidence and Advanced Therapeutic Research at the Diabetic Foot Global Conference (DFCon) 2009
10. ULURU Inc. Announces the Commencement of First Clinical Study Using Altrazeal(TM) Silver
11. Pharmasset Announces Proposed Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... May 29, 2015  Epic Sciences announced today that ... from metastatic castrate resistant prostate cancer patients, at ... for Clinical Oncology. This application expands the investigational ... behind™ platform to characterize circulating tumor cell ... stage patients have heterogeneous clonal CTC populations harboring ...
(Date:5/29/2015)... 29, 2015 Amgen (NASDAQ: AMGN ... Phase 3, global, randomized, placebo-controlled trials evaluating AMG ... secondary hyperparathyroidism (SHPT) in patients with chronic kidney ... primary endpoint, demonstrating that a greater proportion of ... greater than 30 percent reduction in parathyroid hormone ...
(Date:5/29/2015)... Pa. , May 29, 2015 ... focus of the Association for the Advancement of ... With support from AAWC,s corporate partners, ... Educational Portal on the AAWC website at ... a wound care pathway with links to various ...
Breaking Medicine Technology:Genetic Analysis of Single Circulating Tumor Cells Shows High Intra-patient Heterogeneity 2Genetic Analysis of Single Circulating Tumor Cells Shows High Intra-patient Heterogeneity 3Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 2Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 3Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 4Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 5Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 6Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 7The Association for the Advancement of Wound Care Educates the Public 2
(Date:5/29/2015)... The science of Follicular Unit Extraction ... and more efficient methods of FUE hair transplantation have increased ... of the most cutting edge hair transplant methods being used ... technique of extracting hair from the beard to the scalp. ... to correct male pattern baldness. Beard hair has a ...
(Date:5/29/2015)... May 29, 2015 On May 21, 2015, ... be When You Get Botox ?” reported on the ... Google. Elle partnered with Google to determine these results and ... searched question in California, for example, is how to ... common search query is what's the appropriate age to start ...
(Date:5/29/2015)... To compile the list, the Becker's Hospital ... several awards for clinical and general excellence. The team ... to them in terms of overall excellence, and those ... 50 Great Health Systems to Know 2015 list includes ... Fla.) , Advocate Health Care (Downers Grove, Ill.) , ...
(Date:5/29/2015)... California (PRWEB) May 29, 2015 A group ... and have joined the national effort to teach this “new ... in the U.S. have been “sickened” by the recent implementation ... love it or hate it, Common Core is now a ... of Columbia. Parents are now seeking ways to improve ...
(Date:5/29/2015)... 2015 Inspire Nexus, a new social ... to the question many life coaches have asked, "How ... and hours necessary to become a credentialed Coach?" , ... but not for long. Inspire Nexus, a social network ... directly. Coaches who have experience coaching a certain number ...
Breaking Medicine News(10 mins):Health News:Beard to Scalp Hair Transplant: Newest Advance in Hair Transplant Technology 2Health News:Botox, Wrinkles and Double Chins: The Most-Asked Beauty Problems According to Google 2Health News:Becker's Hospital Review Names 50 Great Health Systems to Know 2Health News:Becker's Hospital Review Names 50 Great Health Systems to Know 3Health News:Doctors Discover a Cure for the Common Core 2
... The Center for Professional Innovation & Education (CfPIE) announced today ... existing list of highly-successful biotech and pharmaceutical training courses. ... developed to provide life sciences personnel with the kind of ... , ...
... , ... Denver, CO (PRWEB) July 8, 2008 --Innovative Routines ... FL, has just recorded its 30th year in the software industry ... in particular. IRI's flagship CoSort product is used worldwide in legacy ...
... to recruit large percentage of African American ... ... double,a person,s weight loss according to a study from Kaiser Permanente,s Center,for ... loss maintenance trials ever conducted, will be published in,the August issue of ...
... 7 Accuray,Incorporated (Nasdaq: ARAY ), a global ... will report results for its fourth quarter and,fiscal year ... 2008 after,the market closes., A conference call to ... p.m. EDT) and will be hosted by Euan S. ...
... Calif., July 7 Nationwide,Health Properties, Inc. (NYSE: ... second quarter earnings on Wednesday, August 6, 2008 after ... The Company will host a,conference call on Thursday, August ... time) in order to present the Company,s financial,performance and ...
... molecular "smart bombs" to target metastasis with anti-cancer drugs ... toxic chemotherapy, with less collateral damage to surrounding tissue, ... University of California, San Diego. By designing a ... led by Moores UCSD Cancer Center Director of Translational ...
Cached Medicine News:Health News:The Center for Professional Innovation and Education (CfPIE) Announces a New Global Regulatory Certification Track 2Health News:The Center for Professional Innovation and Education (CfPIE) Announces a New Global Regulatory Certification Track 3Health News:IRI, The CoSort Company, Marks 30 Years 2Health News:IRI, The CoSort Company, Marks 30 Years 3Health News:Kaiser Permanente Study Finds Keeping a Food Diary Doubles Diet Weight Loss 2Health News:Kaiser Permanente Study Finds Keeping a Food Diary Doubles Diet Weight Loss 3Health News:Kaiser Permanente Study Finds Keeping a Food Diary Doubles Diet Weight Loss 4Health News:Accuray Incorporated to Report Fourth Quarter and Fiscal Year 2008 Financial Results 2Health News:NHP Announces Second Quarter Earnings Release Date and Conference Call/Webcast 2Health News:NHP Announces Second Quarter Earnings Release Date and Conference Call/Webcast 3Health News:'Smart bomb' nanoparticle strategy impacts metastasis 2
Inquire...
Quick Release Holder for the 8000 Series Sliding Microtome. A simple to use hlder for wax cassettes. Accepts standard size wax cassettes (26 x 31 x 5mm). Can be specified instead of standard vice ...
Tilt Adapter for the 8000 Sliding Microtome to allow for orientation of the specimen....
... new SureCut M3500 Radial Microtome has a look ... and a range of functions and capabilities that ... Based on years of experience and knowledge but ... the SureCut M3500 Microtome will be the answer ...
Medicine Products: